2Arends JW. Molecular interactions in the vogelstein model of colorectal carcinoma[J]. Pathal, 2000,190(4) :412-415.
3Willmans C, Grossmann J, Steinhaller S, et al. Soluble serum Ecaclherin as a marker of tumour progression in colorectal cancer patients [J]. Clim Exp Metastasis, 2004,21(1) :75-76.
1Arends JW. Molecular interactions in the Vogelstein model of colorectal carcinoma. J Pathol,2000, 190(4):412-416.
2Kim KY ,Jeong SY, Won J,et al. Induction of angiogenesis by expression of soluble type II transforming growth factor-beta receptor in mouse hepatoma.J Biol Chem, 2001,276(42):38781-38786.
3Akiba J,Yano H,Ogasawara S, et al. Expression and function of interleulin-8 in human hepatocellular carcinoma. Int J Oncol, 2001,18(2):257-264.
4Ren Y,Poon RT,Tsui HT,et al.Interleukin-8 serum levels in patients with hepatoeellular carcinoma:correlations with elinieopathologieal features and prognosis.Clin Cancer Res,2003,9(16ptl):5996-6001.
1Vergara Fernandez O,Swallow CJ,Victor JC,et al.Assessingoutcomes following surgery for colorectal cancer using quality ofcare indicators[J].Can J Surg,2010,53(4):232-240.
